BIO Proposes Increased Imputed Base Rates for 2002 Medicare OPPS

The Biotechnology Industry Organization (BIO) says it will seek a blended reimbursement rate of 80% of the average wholesale price (AWP) for drugs and biologics if the trade group is unable to delay the Centers for Medicare & Medicaid Services' 68.9% pro rata reduction in "pass-through" payments for new medical technologies